Bridging the Valley-of-Death to Create a Path to Successes, a Case for Publically Funded Drug Discovery.
Written by Associate Professor Bernard Flynn The Opportunity: The pharmaceutical sector is one of the most profitable industries in the world. The top 10 selling drugs all have annual sales in excess of US$6 bil pa. In the last 20 yrs the sector has been transformed, with many larger Pharma companies preferring to build […]VIEW POST
Dan Baker, M.D., Disease Area Stronghold Leader, Rheumatoid Arthritis, Janssen Research & Development talks about translating biomedical research.VIEW POST
Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
Written by Dr Geoff Garrett AO FTSE, Chief Scientist of Queensland. SCIENCE VISION Winston Churchill: “The further backward you can look, the further forward you can see”. Steve Jobs: “You can’t connect the dots looking forward; you can only connect them looking backwards”. The Human Genome Project, completed in 2003, took 13 years and cost $2.7 billion. […]VIEW POST
Australia excels in biomedical research but sucks at commercialisation. Professor Frank Gannon says that needs to change. This article, written by Graeme O’Neill, previously appeared in Lab + Life Scientist. Professor Gannon is director of the QIMR Berghofer Medical Research Institute, formerly known as the Queensland Institute of Medical Research. The institute is dedicated to […]VIEW POST
Previous posts: Part 1, Part 2 Part 3 of looking back through the microscope at medical research attempts to encourage conversation about making effective, strategic social investments in biomedical research. As with any business, donor or government, resources are not infinite and outcomes are best achieved by getting the balance right in what is supported […]VIEW POST
Part 1 of this blog started with a conversation looking at current funding models and the way they influence the priorities of researchers and their institutions. Part 2 continues to prompt the conversation by looking at the relationship between these measures, publications and the delivery of impact from biomedical research. The funding models […]VIEW POST